Business - Briefly   

Wockhardt completes Negma Lab acquisition

BANGALORE: Wockhardt on Thursday announced the completion of the acquisition of Negma Laboratories, the fourth largest independent, integrated pharmaceutical group in France with sales of $150 million. Negma is Wockhardt's fifth acquisition in Europe after Wallis, CP Pharmaceuticals (both in the U.K.), Esparma in Germany and Pinewood Laboratories in Ireland. Wockhardt has made successful integrations and value creation in all its former acquisitions.

Printer friendly page  
Send this article to Friends by E-Mail

Stories in this Section

Bajaj spins off three separate entities
Tata Steel net up at Rs. 4,222 cr.
RBI issues draft guidelines on credit default swaps
Accenture, MIT join hands to offer training
McAfee to expand presence
Sensex up 172 points
Rupee reacts against dollar
`Govt. stake not to fall below 51 p.c. in PSBs'
Exchange rates
Bullion rates
Enam Insurance Broker gets IRDA licence
Barclays launches retail banking
HDFC Bank to raise Rs. 4,200 crore
Maruti cars dearer by up to Rs. 4,300
Wockhardt completes Negma Lab acquisition
Idea, Nokia Siemens sign contract
Grasim to open more exclusive outlets
City Corporation launches Amanora Park Town
Media One plans to acquire 20 more theatres
Yahoo! launches OneSearch

Copyright © 2007, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu